Luca Issi
Stock Analyst at RBC Capital
(3.78)
# 688
Out of 5,067 analysts
219
Total ratings
50%
Success rate
7.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $24.15 | +3.52% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $26.49 | +5.70% | 1 | Nov 20, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $45 → $52 | $44.26 | +17.49% | 10 | Nov 19, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $5.90 | +35.59% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $42 → $50 | $51.25 | -2.44% | 15 | Nov 11, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $17 → $19 | $12.23 | +55.36% | 11 | Nov 7, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Sector Perform | $14 → $9 | $8.35 | +7.78% | 7 | Nov 7, 2025 | |
| DYN Dyne Therapeutics | Maintains: Outperform | $23 → $30 | $21.67 | +38.44% | 4 | Nov 6, 2025 | |
| QURE uniQure | Maintains: Outperform | $65 → $45 | $27.78 | +61.99% | 7 | Nov 4, 2025 | |
| ARGX argenx SE | Maintains: Outperform | $850 → $860 | $907.42 | -5.23% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $82 | $78.52 | +4.43% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $7 | $11.74 | -40.37% | 2 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $71.20 | +1.12% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $435 → $500 | $434.23 | +15.15% | 28 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $210 → $230 | $209.03 | +10.03% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $4.12 | -2.91% | 8 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.35 | +640.74% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $20.13 | -10.58% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $9.99 | +100.20% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.42 | +380.08% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $12.10 | +40.50% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $7.57 | +71.73% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $10.89 | +221.40% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $23.62 | +10.08% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $55.50 | +26.13% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $35.71 | +59.62% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.50 | +60.00% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $32.78 | +134.90% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $7.46 | +101.07% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.87 | +648.66% | 5 | Aug 7, 2024 |
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $24.15
Upside: +3.52%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $26.49
Upside: +5.70%
Arrowhead Pharmaceuticals
Nov 19, 2025
Maintains: Outperform
Price Target: $45 → $52
Current: $44.26
Upside: +17.49%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $5.90
Upside: +35.59%
CRISPR Therapeutics AG
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $51.25
Upside: -2.44%
REGENXBIO
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $12.23
Upside: +55.36%
Intellia Therapeutics
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $8.35
Upside: +7.78%
Dyne Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $21.67
Upside: +38.44%
uniQure
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $27.78
Upside: +61.99%
argenx SE
Oct 31, 2025
Maintains: Outperform
Price Target: $850 → $860
Current: $907.42
Upside: -5.23%
Oct 30, 2025
Maintains: Outperform
Price Target: $80 → $82
Current: $78.52
Upside: +4.43%
Oct 30, 2025
Maintains: Sector Perform
Price Target: $5 → $7
Current: $11.74
Upside: -40.37%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $71.20
Upside: +1.12%
Sep 19, 2025
Maintains: Outperform
Price Target: $435 → $500
Current: $434.23
Upside: +15.15%
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $209.03
Upside: +10.03%
May 15, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $4.12
Upside: -2.91%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.35
Upside: +640.74%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $20.13
Upside: -10.58%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $9.99
Upside: +100.20%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.42
Upside: +380.08%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $12.10
Upside: +40.50%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $7.57
Upside: +71.73%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $10.89
Upside: +221.40%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $23.62
Upside: +10.08%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $55.50
Upside: +26.13%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $35.71
Upside: +59.62%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.50
Upside: +60.00%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $32.78
Upside: +134.90%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $7.46
Upside: +101.07%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.87
Upside: +648.66%